The product was developed as part of the state strategy for increasing the population's life expectancy and quality of life and improving medicine availability.
JSC “Pharmstandard” informs about the change to the membership of the Company's management and the appointment of Dmitry Ivanovich Zaytsev as Chief Executive Officer.
Potapov...
The investment project will be implemented in 2023–2025. The total amount of investment is estimated to be 2.6 billion rubles.
According to Nail Nizamutdinov, General...
According to the press service of the Government of the Republic of Bashkortostan, Bashkiria quadrupled its production of medicines in July this year. The...